Towards diagnostic guidelines for biofilm-associated infections

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Towards diagnostic guidelines for biofilm-associated infections. / Hall-Stoodley, Luanne; Stoodley, Paul; Kathju, Sandeep; Høiby, Niels; Moser, Claus; William Costerton, J; Moter, Annette; Bjarnsholt, Thomas.

In: F E M S Immunology and Medical Microbiology, Vol. 65, No. 2, 07.2012, p. 127-145.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hall-Stoodley, L, Stoodley, P, Kathju, S, Høiby, N, Moser, C, William Costerton, J, Moter, A & Bjarnsholt, T 2012, 'Towards diagnostic guidelines for biofilm-associated infections', F E M S Immunology and Medical Microbiology, vol. 65, no. 2, pp. 127-145. https://doi.org/10.1111/j.1574-695X.2012.00968.x

APA

Hall-Stoodley, L., Stoodley, P., Kathju, S., Høiby, N., Moser, C., William Costerton, J., Moter, A., & Bjarnsholt, T. (2012). Towards diagnostic guidelines for biofilm-associated infections. F E M S Immunology and Medical Microbiology, 65(2), 127-145. https://doi.org/10.1111/j.1574-695X.2012.00968.x

Vancouver

Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, William Costerton J et al. Towards diagnostic guidelines for biofilm-associated infections. F E M S Immunology and Medical Microbiology. 2012 Jul;65(2):127-145. https://doi.org/10.1111/j.1574-695X.2012.00968.x

Author

Hall-Stoodley, Luanne ; Stoodley, Paul ; Kathju, Sandeep ; Høiby, Niels ; Moser, Claus ; William Costerton, J ; Moter, Annette ; Bjarnsholt, Thomas. / Towards diagnostic guidelines for biofilm-associated infections. In: F E M S Immunology and Medical Microbiology. 2012 ; Vol. 65, No. 2. pp. 127-145.

Bibtex

@article{5d2ee841eed4461ebc9c5dc773e67617,
title = "Towards diagnostic guidelines for biofilm-associated infections",
abstract = "Biofilms associated with the human body, particularly in typically sterile locations, are difficult to diagnose and treat effectively because of their recalcitrance to conventional antibiotic therapy and host immune responses. The study of biofilms in medicine today requires a translational approach, with examination of clinically relevant biofilms in the context of specific anatomic sites, host tissues, and diseases, focusing on what can be done to mitigate their pathologic consequences. This review, which grew out of a discussion session on clinical biofilms at the 5th ASM Biofilm Conference in Cancun, Mexico, is designed to give an overview of biofilm-associated infections (BAI) and to propose a platform for further discussion that includes clinicians, medical microbiologists, and biofilm researchers who are stakeholders in advancing the scientific pursuit of better diagnosis and treatment of BAI to mitigate their human and healthcare costs. It also highlights the need for better diagnostic markers, which exploit the difference between planktonic and biofilm cells.",
author = "Luanne Hall-Stoodley and Paul Stoodley and Sandeep Kathju and Niels H{\o}iby and Claus Moser and {William Costerton}, J and Annette Moter and Thomas Bjarnsholt",
note = "{\textcopyright} 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.",
year = "2012",
month = jul,
doi = "10.1111/j.1574-695X.2012.00968.x",
language = "English",
volume = "65",
pages = "127--145",
journal = "F E M S Immunology and Medical Microbiology",
issn = "0928-8244",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Towards diagnostic guidelines for biofilm-associated infections

AU - Hall-Stoodley, Luanne

AU - Stoodley, Paul

AU - Kathju, Sandeep

AU - Høiby, Niels

AU - Moser, Claus

AU - William Costerton, J

AU - Moter, Annette

AU - Bjarnsholt, Thomas

N1 - © 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

PY - 2012/7

Y1 - 2012/7

N2 - Biofilms associated with the human body, particularly in typically sterile locations, are difficult to diagnose and treat effectively because of their recalcitrance to conventional antibiotic therapy and host immune responses. The study of biofilms in medicine today requires a translational approach, with examination of clinically relevant biofilms in the context of specific anatomic sites, host tissues, and diseases, focusing on what can be done to mitigate their pathologic consequences. This review, which grew out of a discussion session on clinical biofilms at the 5th ASM Biofilm Conference in Cancun, Mexico, is designed to give an overview of biofilm-associated infections (BAI) and to propose a platform for further discussion that includes clinicians, medical microbiologists, and biofilm researchers who are stakeholders in advancing the scientific pursuit of better diagnosis and treatment of BAI to mitigate their human and healthcare costs. It also highlights the need for better diagnostic markers, which exploit the difference between planktonic and biofilm cells.

AB - Biofilms associated with the human body, particularly in typically sterile locations, are difficult to diagnose and treat effectively because of their recalcitrance to conventional antibiotic therapy and host immune responses. The study of biofilms in medicine today requires a translational approach, with examination of clinically relevant biofilms in the context of specific anatomic sites, host tissues, and diseases, focusing on what can be done to mitigate their pathologic consequences. This review, which grew out of a discussion session on clinical biofilms at the 5th ASM Biofilm Conference in Cancun, Mexico, is designed to give an overview of biofilm-associated infections (BAI) and to propose a platform for further discussion that includes clinicians, medical microbiologists, and biofilm researchers who are stakeholders in advancing the scientific pursuit of better diagnosis and treatment of BAI to mitigate their human and healthcare costs. It also highlights the need for better diagnostic markers, which exploit the difference between planktonic and biofilm cells.

U2 - 10.1111/j.1574-695X.2012.00968.x

DO - 10.1111/j.1574-695X.2012.00968.x

M3 - Journal article

C2 - 22469292

VL - 65

SP - 127

EP - 145

JO - F E M S Immunology and Medical Microbiology

JF - F E M S Immunology and Medical Microbiology

SN - 0928-8244

IS - 2

ER -

ID: 38135450